Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
We have now added a new section called the "Assay History List" to the "At A Gla...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...